The decision from Cleveland County District Judge Thad Balkman is expected this afternoon. The case is closely watched as a bellwether for other pending litigation against drugmakers. Meanwhile, investigators are starting to utilize data to combat the opioid crisis, new information emerges about a company the DEA once referred to as the "kingpin within the prescription drug cartel," and scientists look at how gender plays a role in pain.
from Kaiser Health News https://ift.tt/326wtce
August 26, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
More Americans Sent Home From China After Being Struck With Mysterious IllnessThe tally of affected diplomats keeps growing, but officials still don't have an answer to what's at the root of the cause of the traumatic brain injuries. from Kaiser Health News https://ift.tt/2KqkLFg … Read More
‘I Watched Him Die Over Many Years’: Families Struggle To Cope With Loved Ones’ Decades-Long AddictionsWatching a loved one struggle with addiction can be a source of constant stress and take a physical toll in the long run. In other news on the crisis: violence in emergency rooms, blue-lit bathrooms, and legal action against … Read More
As Health Policy Action Shifts To States, Insurance Landscape Starting To Revert To Hodgepodge Of Years PastBefore the federal health law, geography played a large role in Americans' ability to get affordable coverage. Now, as some states take advantage of the administration's relaxation of restrictions and others work to build up … Read More
Viewpoints: Fight Back Against The Ban On Soda Taxes; Stop Using Opioid Prescriptions As Easy FixOpinion pages look at these and other health issues. from Kaiser Health News https://ift.tt/2tOsna9 … Read More
Jury Sides With Patient That $229,112.13 Hospital Bill Was UnreasonableDisputes over astronomical hospital prices are moving into the courts as more employers refuse to pay for their workers' full bills. Meanwhile, to deal with skyrocketing health costs, some patients are turning to crowdfunding… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment